![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
(MM) | NASDAQ:IDIX | NASDAQ | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.50 | 0.00 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
o Rule 13d-1(b)
o Rule 13d-1(c)
þ Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No.
|
45166R 20 4
|
1 |
NAMES OF REPORTING PERSONS
BB BioVentures L.P. |
||||
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 2,949,488 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 2,949,488 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
2,949,488 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
4.0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
PN |
Page 2 of 18
CUSIP No.
|
45166R 20 4
|
1 |
NAMES OF REPORTING PERSONS
MPM BioVentures Parallel Fund, L.P. |
||||
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 256,519 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 256,519 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
256,519 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
0.4% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
PN |
Page 3 of 18
CUSIP No.
|
45166R 20 4
|
1 |
NAMES OF REPORTING PERSONS
MPM Asset Management Investors 1998 LLC |
||||
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 37,299 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 37,299 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
37,299 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
0.1% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
OO |
Page 4 of 18
CUSIP No.
|
45166R 20 4
|
1 |
NAMES OF REPORTING PERSONS
MPM Asset Management LLC |
||||
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 78,228 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 78,228 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
78,228 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
0.1% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
OO |
Page 5 of 18
CUSIP No.
|
45166R 20 4
|
1 |
NAMES OF REPORTING PERSONS
MPM BioVentures I, L.P. |
||||
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 256,519* | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 256,519* | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
256,519* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
0.4% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
PN |
Page 6 of 18
CUSIP No.
|
45166R 20 4
|
1 |
NAMES OF REPORTING PERSONS
MPM BioVentures I LLC |
||||
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 3,206,007* | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 3,206,007* | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
3,206,007* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
4.4% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
OO |
Page 7 of 18
CUSIP No.
|
45166R 20 4
|
1 |
NAMES OF REPORTING PERSONS
BAB BioVentures L.P. |
||||
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 2,949,488* | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 2,949,488* | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
2,949,488* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
4.0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
PN |
Page 8 of 18
CUSIP No.
|
45166R 20 4
|
1 |
NAMES OF REPORTING PERSONS
BAB BioVentures, N.V. |
||||
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Netherlands Antilles | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 2,949,488* | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 0 | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 2,949,488* | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
2,949,488* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
4.0% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
PN |
Page 9 of 18
CUSIP No.
|
45166R 20 4
|
1 |
NAMES OF REPORTING PERSONS
Ansbert Gadicke |
||||
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
United States | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 3,321,534* | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
3,321,534* | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
3,321,534* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
4.6% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
IN |
Page 10 of 18
CUSIP No.
|
45166R 20 4
|
1 |
NAMES OF REPORTING PERSONS
Luke Evnin |
||||
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
United States | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 3,321,534* | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
3,321,534* | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
3,321,534* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
4.6% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
IN |
Page 11 of 18
CUSIP No.
|
45166R 20 4
|
1 |
NAMES OF REPORTING PERSONS
Michael Steinmetz |
||||
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
||||
(a) o | |||||
(b) þ | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
United States | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 0 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | 3,243,306* | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 0 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
3,243,306* | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
3,243,306* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
4.5% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
IN |
Page 12 of 18
(a) |
Name of Issuer
Idenix Pharmaceuticals, Inc. |
||
(b) |
Address of Issuers Principal Executive Offices
60 Hampshire Street Cambridge, MA 02139 |
(a) |
Name of Person Filing
|
(b) |
Address of Principal Business Office or, if none, Residence
|
(c) |
Citizenship
|
(d) |
Title of Class of Securities
|
(e) |
CUSIP Number
|
Item 3. |
If this statement is filed pursuant to §§240.13d-
1(b)
, or 240.13d-
2(b)
or (c), check
whether the person filing is a:
|
Page 13 of 18
Item 4. |
Ownership
|
(a) |
Amount Beneficially Owned:
|
BB BioVentures, LP
|
2,949,488 | |||
MPM BioVentures Parallel Fund, LP
|
256,519 | |||
MPM Asset Management Investors 1998 LLC
|
37,299 | |||
MPM Asset Management LLC
|
78,228 | |||
MPM BioVentures I, L.P.
|
256,519 | (1) | ||
MPM BioVentures I LLC
|
3,206,007 | (2) | ||
BAB BioVentures L.P.
|
2,949,488 | (3) | ||
BAB BioVentures, N.V.
|
2,949,488 | (4) | ||
Ansbert Gadicke
|
3,321,534 | (5) | ||
Luke Evnin
|
3,321,534 | (5) | ||
Michael Steinmetz
|
3,243,306 | (6) |
(b) |
Percent of Class:
|
BB BioVentures, LP
|
4.0 | % | ||
MPM BioVentures Parallel Fund, LP
|
0.4 | % | ||
MPM Asset Management Investors 1998 LLC
|
0.1 | % | ||
MPM Asset Management LLC
|
0.1 | % | ||
MPM BioVentures I, L.P.
|
0.4 | % | ||
MPM BioVentures I LLC
|
4.4 | % | ||
BAB BioVentures L.P.
|
4.0 | % | ||
BAB BioVentures, N.V.
|
4.0 | % | ||
Ansbert Gadicke
|
4.6 | % | ||
Luke Evnin
|
4.6 | % | ||
Michael Steinmetz
|
4.5 | % |
(c) |
Number of shares as to which the person has:
|
(i) |
Sole power to vote or to direct the vote
|
BB BioVentures, LP
|
2,949,488 | |||
MPM BioVentures Parallel Fund, LP
|
256,519 | |||
MPM Asset Management Investors 1998 LLC
|
37,299 | |||
MPM Asset Management LLC
|
78,228 | |||
MPM BioVentures I, L.P.
|
0 | |||
MPM BioVentures I LLC
|
0 | |||
BAB BioVentures L.P.
|
0 | |||
BAB BioVentures, N.V.
|
0 | |||
Ansbert Gadicke
|
0 | |||
Luke Evnin
|
0 | |||
Michael Steinmetz
|
0 |
Page 14 of 18
(ii) |
Shared power to vote or to direct the vote
|
BB BioVentures, LP
|
0 | |||
MPM BioVentures Parallel Fund, LP
|
0 | |||
MPM Asset Management Investors 1998 LLC
|
0 | |||
MPM Asset Management LLC
|
0 | |||
MPM BioVentures I, L.P.
|
256,519 | (1) | ||
MPM BioVentures I LLC
|
3,206,007 | (2) | ||
BAB BioVentures L.P.
|
2,949,488 | (3) | ||
BAB BioVentures, N.V.
|
2,949,488 | (4) | ||
Ansbert Gadicke
|
3,321,534 | (5) | ||
Luke Evnin
|
3,321,534 | (5) | ||
Michael Steinmetz
|
3,243,306 | (6) |
(iii) |
Sole power to dispose or to direct the disposition of
|
BB BioVentures, LP
|
2,949,488 | |||
MPM BioVentures Parallel Fund, LP
|
256,519 | |||
MPM Asset Management Investors 1998 LLC
|
37,299 | |||
MPM Asset Management LLC
|
78,228 | |||
MPM BioVentures I, L.P.
|
0 | |||
MPM BioVentures I LLC
|
0 | |||
BAB BioVentures L.P.
|
0 | |||
BAB BioVentures, N.V.
|
0 | |||
Ansbert Gadicke
|
0 | |||
Luke Evnin
|
0 | |||
Michael Steinmetz
|
0 |
(iv) |
Shared power to dispose or to direct the disposition of
|
BB BioVentures, LP
|
0 | |||
MPM BioVentures Parallel Fund, LP
|
0 | |||
MPM Asset Management Investors 1998 LLC
|
0 | |||
MPM Asset Management LLC
|
0 | |||
MPM BioVentures I, L.P.
|
256,519 | (1) | ||
MPM BioVentures I LLC
|
3,206,007 | (2) | ||
BAB BioVentures L.P.
|
2,949,488 | (3) | ||
BAB BioVentures, N.V.
|
2,949,488 | (4) | ||
Ansbert Gadicke
|
3,321,534 | (5) | ||
Luke Evnin
|
3,321,534 | (5) | ||
Michael Steinmetz
|
3,243,306 | (6) |
(1) |
The shares are held by MPM BioVentures Parallel Fund, L.P. (MPM Parallel), of which the
Reporting Person is its general partner.
|
Page 15 of 18
(2) |
The shares are held as follows: 256,519 by MPM Parallel and 2,949,488 by BB BioVentures, L.P.
(BB BioVentures). The Reporting Person is the indirect general partner of MPM Parallel and BB
BioVentures.
|
|
(3) |
The shares are held by BB BioVentures, of which the Reporting Person is the direct general
partner.
|
|
(4) |
The shares are held by BB BioVentures, of which the Reporting Person is the indirect general
partner.
|
|
(5) |
The shares are held as follows: 2,949,488 by BB BioVentures, 256,519 by MPM Parallel, 37,299
by MPM Asset Management Investors 1998 LLC (MPM Investors) and 78,228 by MPM Asset Management LLC
(AM LLC). MPM BioVentures I, L.P. and MPM BioVentures I LLC (BioVentures LLC) are the direct
and indirect general partners of MPM Parallel. BAB BioVentures L.P. (BAB BV), BAB BioVentures NV
and BioVentures LLC are the direct and indirect general partners of BB BioVentures. The Reporting
Person is a manager of MPM Investors and BioVentures LLC and a member of AM LLC.
|
|
(6) |
The shares are held as follows: 2,949,488 by BB BioVentures, 256,519 by MPM Parallel and
37,299 by MPM Investors. MPM BioVentures I, L.P. and BioVentures LLC are the direct and indirect
general partners of MPM Parallel. BAB BV, BAB BioVentures NV and BioVentures LLC are the direct
and indirect general partners of BB BioVentures. The Reporting Person is a manager of MPM
Investors and BioVentures LLC.
|
Item 5. |
Ownership of Five Percent or Less of a Class
|
Item 6. |
Ownership of More than Five Percent on Behalf of Another Person
|
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being
Reported on By the Parent Holding Company or Control Person.
|
Item 8. |
Identification and Classification of Members of the Group
|
Item 9. |
Notice of Dissolution of a Group
|
Item 10. |
Certification
|
Page 16 of 18
BB BIOVENTURES L.P. | MPM BIOVENTURES PARALLEL FUND, L.P. | |||||||||||
|
||||||||||||
By: | BAB BioVentures L.P., | By: | MPM BioVentures I LP, | |||||||||
its General Partner | its General Partner | |||||||||||
|
||||||||||||
By: | BAB BioVentures N.V., | By: | MPM BioVentures I LLC, | |||||||||
its General Partner | its General Partner | |||||||||||
|
||||||||||||
By: | /s/ Luke B. Evnin | By: | /s/ Luke B. Evnin | |||||||||
|
Name: | Luke B. Evnin | Name: | Luke B. Evnin | ||||||||
|
Title: | Manager | Title: | Manager | ||||||||
|
||||||||||||
MPM ASSET MANAGEMENT INVESTORS 1998 LLC | MPM ASSET MANAGEMENT LLC | |||||||||||
|
||||||||||||
By: | /s/ Luke B. Evnin | By: | /s/ Luke B. Evnin | |||||||||
|
Name: | Luke B. Evnin | Name: | Luke B. Evnin | ||||||||
|
Title: | Manager | Title: | Member | ||||||||
|
||||||||||||
MPM BIOVENTURES I, L.P. | MPM BIOVENTURES I LLC | |||||||||||
|
||||||||||||
By: | MPM BioVentures I LLC, | |||||||||||
its General Partner | ||||||||||||
|
||||||||||||
By: | /s/ Luke B. Evnin | By: | /s/ Luke B. Evnin | |||||||||
|
Name: | Luke B. Evnin | Name: | Luke B. Evnin | ||||||||
|
Title: | Manager | Title: | Manager | ||||||||
|
||||||||||||
BAB BIOVENTURES, L.P. | BAB BIOVENTURES, N.V. | |||||||||||
|
||||||||||||
By: | BAB BioVentures, N.V. | By: | /s/ Luke B. Evnin | |||||||||
|
its General Partner | Name: | Luke B. Evnin | |||||||||
|
Title: | Manager | ||||||||||
By: | /s/ Luke B. Evnin | |||||||||||
|
Name: | Luke B. Evnin | ||||||||||
|
Title: | Manager | ||||||||||
|
||||||||||||
/s/ Ansbert Gadicke | ||||||||||||
Ansbert Gadicke | ||||||||||||
|
||||||||||||
/s/ Luke B. Evnin | ||||||||||||
Luke B. Evnin | ||||||||||||
|
||||||||||||
/s/ Michael Steinmetz | ||||||||||||
Michael Steinmetz |
Page 17 of 18
BB BIOVENTURES L.P. | MPM BIOVENTURES PARALLEL FUND, L.P. | |||||||||
|
||||||||||
By: | BAB BioVentures L.P., | By: | MPM BioVentures I LP, | |||||||
its General Partner | its General Partner | |||||||||
|
||||||||||
By: | BAB BioVentures N.V., | By: | MPM BioVentures I LLC, | |||||||
its General Partner | its General Partner | |||||||||
|
||||||||||
By: | /s/ Luke B. Evnin | By: | /s/ Luke B. Evnin | |||||||
|
Name: | Luke B. Evnin | Name: | Luke B. Evnin | ||||||
|
Title: | Manager | Title: | Manager | ||||||
|
||||||||||
MPM ASSET MANAGEMENT INVESTORS 1998 LLC | MPM ASSET MANAGEMENT LLC | |||||||||
|
||||||||||
By: | /s/ Luke B. Evnin | By: | /s/ Luke B. Evnin | |||||||
|
Name: | Luke B. Evnin | Name: | Luke B. Evnin | ||||||
|
Title: | Manager | Title: | Member | ||||||
|
||||||||||
MPM BIOVENTURES I, L.P. | MPM BIOVENTURES I LLC | |||||||||
|
||||||||||
By: | MPM BioVentures I LLC, | |||||||||
its General Partner | ||||||||||
|
||||||||||
By: | /s/ Luke B. Evnin | By: | /s/ Luke B. Evnin | |||||||
|
Name: | Luke B. Evnin | Name: | Luke B. Evnin | ||||||
|
Title: | Manager | Title: | Manager | ||||||
|
||||||||||
BAB BIOVENTURES, L.P. | BAB BIOVENTURES, N.V. | |||||||||
|
||||||||||
By: | BAB BioVentures, N.V. | By: | /s/ Luke B. Evnin | |||||||
|
its General Partner | Name: | Luke B. Evnin | |||||||
|
Title: | Manager | ||||||||
By: | /s/ Luke B. Evnin | |||||||||
|
Name: | Luke B. Evnin | ||||||||
|
Title: | Manager | ||||||||
|
||||||||||
/s/ Ansbert Gadicke | ||||||||||
Ansbert Gadicke | ||||||||||
|
||||||||||
/s/ Luke B. Evnin | ||||||||||
Luke B. Evnin | ||||||||||
|
||||||||||
/s/ Michael Steinmetz | ||||||||||
Michael Steinmetz |
Page 18 of 18
1 Year (MM) Chart |
1 Month (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions